Clinical Trial Update: A Phase II Study of MRG003 Injection Combined With Pucotenlimab Injection ± Cisplatin Injection in the Neoadjuvant Treatment Locally Advanced EGFR-positive Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II neoadjuvant trial evaluating MRG003 with Pucotenlimab, with or without cisplatin, for EGFR-positive locally advanced head and neck squamous cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• MRG003
• Pucotenlimab

Snippet

Sponsor: Lei Liu | Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 2 | Status: NOT_YET_RECRUITING